SOLID DISPERSION: A REVIEW
Journal Title: Indo American Journal of Pharmaceutical Research - Year 2017, Vol 7, Issue
Abstract
Abstract The solubility issues complicating the delivery of the new drugs and also affect the delivery of many existing drugs. There are various techniques are available for enhancement of solubility. Solid dispersion is one of the most promising approaches for solubility enhancement. Currently only 8% of new drug candidates have both high solubility and permeability. More than 60% of potential drug products suffer from poor water solubility. In solid dispersion particle size of drug is reduced or a crystalline pure drug is converted into amorphous form and hence the solubility of drug is increased. Polymers incorporated in solid dispersion technologies are usually hydrophilic in nature and also showing compatibility with the drug to enhance the drug solubility.
Authors and Affiliations
M. E. Potkule*, A. D. Savkare, S. K. Sarode, P. S. Kalaskar
FORMULATION AND EVALUATION OF DORSOLAMIDE HCL OCULAR INSERT
Matrix type of ocular insert was prepared using hydrophilic polymer PVP K 30 in different concentration by solvent casting method. The compatibility study of drug and polymer was performed by FTIR and DSC study and resul...
VALIDATED FOR THE ESTIMATION OF AMLODIPINE IN HUMAN PLASMA OVER
The present study aims to develop the bio-analytical method for the estimation of amlodipine in human plasma and evaluate the pharmacokinetic variables after a single oral dose in eight healthy male human volunteers in a...
ROLE OF HYDROPHILIC POLYMERS ON THE STABILITY OF FORMULATIONS OF TENOXICAM – SBE7-β-CD INCLUSION COMPLEX
The present study was carried out to evaluate the usefulness of sulfobutyl ether β-Cyclodextrin (SBE7-β-CD) in increasing the dissolution rate of tenoxicam. The approach employed to prepare the inclusion complexes of the...
A REVIEW ON MEDICINAL PLANTS AND HERBAL DRUG FORMULATIONS USED IN DIABETES MELLITUS
Diabetes mellitus is a metabolic disorder in the endocrine system. This dreadful disease is found in all parts of the world and is becoming a serious threat to mankind health. It is caused by the deficiency or ineffectiv...
MONITORING OF ADVERSE DRUG REACTIONS (ADR) IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS TREATED WITH IMATINIB AT A TERTIARY CARE HOSPITAL
Imatinib is a tyrosine kinase inhibitor and potently inhibits protein tyrosine kinases which include BCR-ABL which is constitutively active in CML. It targets the ATP binding site of receptors. The present investigation...